Crossmark

Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s10554-021-02443-5

Published Online: 2021-10-20

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ersbøll, Mads

Jürgens, Mikkel

Hasbak, Philip

Kjær, Andreas

Wolsk, Emil

Zerahn, Bo

Brandt-Jacobsen, Niels H.

Gæde, Peter

Rossing, Peter

Faber, Jens

Inzucchi, Silvio E.

Gustafsson, Finn

Schou, Morten

Kistorp, Caroline
License Information

Text and Data Mining valid from 2021-10-20

Version of Record valid from 2021-10-20
More Information

Article History

Received: 10 August 2021

Accepted: 10 October 2021

First Online: 20 October 2021

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below